# Psychiatry Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Nikola Tesla (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI009-SYN-TD
- Date: 1902-01-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Leah Feinberg-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Branimir Kovač-Holt, MD

## Reason for consultation

Severe obsessive-compulsive symptoms (Y-BOCS 28) with good insight in a 45-year-old electrical engineer, with weight loss from food rituals and hand dermatitis from washing. Please confirm the diagnosis, review comorbidity, and advise on sertraline dosing, the length of the trial, and what to do if the response is partial. **S**

## History

Mr. Tesla is seen at the request of Dr. Kovač-Holt, two weeks after starting sertraline 50 mg, which he tolerates with brief nausea. He describes contamination, symmetry, and number obsessions since childhood that have waxed and waned and worsened over the past six months under work pressure, with washing, counting, repeating, and calculating compulsions that take three to four hours a day. He resists them at a cost of rising anxiety and recognizes them as excessive. He has no motor or vocal tics, no period of elevated mood or reduced need for sleep with racing thoughts beyond his long-standing short sleep, no hallucinations or fixed false beliefs, no hoarding, and no concern about his appearance. His vivid imagery of designs is voluntary and recognized as his own. His perfectionism is confined to the rituals he finds distressing and does not otherwise rule his relationships. He does not fear weight gain or dislike his body shape; he skips meals because calculating them is exhausting. He has never harmed himself and has no suicidal thoughts. He drinks rarely and uses no drugs. **S**

## Examination

| System | Finding |
|---|---|
| Appearance and behavior | Very tall, thin, immaculately dressed; courteous; declined a handshake; asked to wash his hands, which was arranged |
| Speech | Formal, precise, and fluent |
| Mood and affect | Mood "the same, but hopeful"; affect anxious |
| Thought | Linear and detailed; obsessions about contamination and numbers with good insight; no delusions or hallucinations; no suicidal or homicidal ideation |
| Cognition, insight, and judgment | Alert and oriented; insight and judgment good |

BP 114/70 mmHg; pulse 72 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 63.9 kg; BMI 18.1 kg/m². All vital signs are synthetic.

## Data reviewed

The intake history, Y-BOCS 28 and today's 27, PHQ-9, GAD-7, AUDIT-C, the laboratory results, the weight, and the collaborative safety plan. 

## Assessment

1. **Obsessive-compulsive disorder, severe, with good insight** (F42.2). Confirmed: contamination, symmetry, and number obsessions with washing, counting, repeating, and calculating compulsions, severe by the Y-BOCS. No tic disorder, bipolar disorder, psychosis, hoarding, body dysmorphic disorder, or obsessive-compulsive personality disorder. The restricted eating is driven by the calculating ritual, not by fear of weight gain or of choking, so it is treated within the OCD plan rather than as a separate eating disorder. Depressive and anxiety symptoms are secondary. Acute suicide risk is low, and the safety plan is appropriate. **S**
2. **Underweight from food rituals** (R63.6). Needs regular meals now, with eating without calculating built into the exposure plan. **S**

## Recommendations

1. Combine weekly exposure and response prevention with sertraline, given severe symptoms.
2. Keep sertraline at 50 mg for now; if the response is inadequate after four to six weeks, raise it in 50 mg steps every four to six weeks as side effects allow, up to 200 mg, with a check for side effects about two weeks after each increase.
3. Judge the response only after eight to twelve weeks with at least four to six weeks at the top tolerated dose; a fall of 35 percent or more in the Y-BOCS is a response.
4. Rate the Y-BOCS about every four to six weeks during titration; screen mood and suicide risk at each visit.
5. If the response is still inadequate after an adequate trial at the highest tolerated dose, ask psychiatry about a switch to another SSRI or clomipramine, or augmentation, with the monitoring each needs.
6. Continue an effective dose for at least one to two years before any slow taper, with ERP booster sessions.
7. Fixed mealtimes and dietitian support; examinations explained step by step, with hand hygiene offered, and no unplanned exposures outside therapy.

## Strengths and supports

- Supports: his work and its purpose, two long-serving engineers on his staff, and a long walk each day; no firearms in the home **S**

## Communication

Discussed with Dr. Kovač-Holt the same day; Mr. Tesla agrees with the plan. **S**

## Follow-up

Primary care manages treatment with the clinic psychologist. Psychiatry is available for a further consultation on the criteria above. **S**

## Guideline basis

- Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007), American Psychiatric Association
- Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013), American Psychiatric Association
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005), National Institute for Health and Care Excellence
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
